
Ibrahim D. Bori
Examiner (ID: 18672, Phone: (571)270-7020 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629 |
| Total Applications | 763 |
| Issued Applications | 313 |
| Pending Applications | 85 |
| Abandoned Applications | 385 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15571443
[patent_doc_number] => 10576080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Compounds and compositions as protein kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/818082
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21307
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15818082
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/818082 | Compounds and compositions as protein kinase inhibitors | Nov 19, 2017 | Issued |
Array
(
[id] => 12723892
[patent_doc_number] => 20180133131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => SKIN REJUVENATING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/812310
[patent_app_country] => US
[patent_app_date] => 2017-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15812310
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/812310 | SKIN REJUVENATING COMPOSITIONS | Nov 13, 2017 | Abandoned |
Array
(
[id] => 14743737
[patent_doc_number] => 20190255042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => APPLICATION OF HEDGEHOG PATHWAY INHIBITOR IN TREATING FIBROSIS DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/347242
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347242 | APPLICATION OF HEDGEHOG PATHWAY INHIBITOR IN TREATING FIBROSIS DISEASES | Nov 1, 2017 | Abandoned |
Array
(
[id] => 13311231
[patent_doc_number] => 20180207152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => ANTICOAGULANT REVERSAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/726497
[patent_app_country] => US
[patent_app_date] => 2017-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15726497
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/726497 | ANTICOAGULANT REVERSAL AGENTS | Oct 5, 2017 | Abandoned |
Array
(
[id] => 12857581
[patent_doc_number] => 20180177701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => HAIR REMOVAL METHODS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/715689
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15715689
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/715689 | HAIR REMOVAL METHODS AND COMPOSITIONS | Sep 25, 2017 | Abandoned |
Array
(
[id] => 12675580
[patent_doc_number] => 20180117026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/705541
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705541
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705541 | COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS | Sep 14, 2017 | Abandoned |
Array
(
[id] => 15338769
[patent_doc_number] => 10525038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Combination therapy
[patent_app_type] => utility
[patent_app_number] => 15/704713
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16075
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15704713
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/704713 | Combination therapy | Sep 13, 2017 | Issued |
Array
(
[id] => 12117216
[patent_doc_number] => 20180000802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENTAL DISEASE WITH ENHANCED NMDAR FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 15/703804
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4542
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703804
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703804 | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENTAL DISEASE WITH ENHANCED NMDAR FUNCTION | Sep 12, 2017 | Abandoned |
Array
(
[id] => 13714197
[patent_doc_number] => 20170368053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD
[patent_app_type] => utility
[patent_app_number] => 15/698365
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698365
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698365 | TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD | Sep 6, 2017 | Abandoned |
Array
(
[id] => 13687339
[patent_doc_number] => 20170354624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => TOPICAL COMPOSITIONS FOR TREATMENT OF SKIN IRRITATION
[patent_app_type] => utility
[patent_app_number] => 15/687607
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687607
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/687607 | TOPICAL COMPOSITIONS FOR TREATMENT OF SKIN IRRITATION | Aug 27, 2017 | Abandoned |
Array
(
[id] => 12808423
[patent_doc_number] => 20180161311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => SYNTHETIC TRITERPENOIDS AND METHODS OF USE IN THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/675862
[patent_app_country] => US
[patent_app_date] => 2017-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15675862
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/675862 | SYNTHETIC TRITERPENOIDS AND METHODS OF USE IN THE TREATMENT OF DISEASE | Aug 13, 2017 | Abandoned |
Array
(
[id] => 17663580
[patent_doc_number] => 11357250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Treatment and prevention of diabetes and obesity
[patent_app_type] => utility
[patent_app_number] => 15/674876
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21052
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674876
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674876 | Treatment and prevention of diabetes and obesity | Aug 10, 2017 | Issued |
Array
(
[id] => 17095306
[patent_doc_number] => 20210283097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHODS OF DIAGNOSING AND TREATING ALZHEIMER'S DISEASE WITH S-EQUOL
[patent_app_type] => utility
[patent_app_number] => 16/320938
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320938
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320938 | METHODS OF DIAGNOSING AND TREATING ALZHEIMER'S DISEASE WITH S-EQUOL | Jul 24, 2017 | Abandoned |
Array
(
[id] => 17633870
[patent_doc_number] => 11344575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Vascular calcification prevention and treatment
[patent_app_type] => utility
[patent_app_number] => 15/649084
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17250
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15649084
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/649084 | Vascular calcification prevention and treatment | Jul 12, 2017 | Issued |
Array
(
[id] => 11993868
[patent_doc_number] => 20170298022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'Diamino-Pyridine, Pyrimidine, and Pyridazine Modulators of the Histamine H4 Receptor'
[patent_app_type] => utility
[patent_app_number] => 15/636325
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63623
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15636325
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/636325 | Diamino-Pyridine, Pyrimidine, and Pyridazine Modulators of the Histamine H4 Receptor | Jun 27, 2017 | Abandoned |
Array
(
[id] => 12057045
[patent_doc_number] => 20170333390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'PHYTOCHEMICAL COMPOSITIONS INCLUDING SESAMIN FOR ANTI-INFLAMMATORY, ANTI-CYTOKINE STORM, AND OTHER USES'
[patent_app_type] => utility
[patent_app_number] => 15/622639
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13578
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15622639
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/622639 | PHYTOCHEMICAL COMPOSITIONS INCLUDING SESAMIN FOR ANTI-INFLAMMATORY, ANTI-CYTOKINE STORM, AND OTHER USES | Jun 13, 2017 | Abandoned |
Array
(
[id] => 12364035
[patent_doc_number] => 09956204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Composition for exterminating scuticociliates in fish including mebendazole
[patent_app_type] => utility
[patent_app_number] => 15/620788
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6370
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15620788
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/620788 | Composition for exterminating scuticociliates in fish including mebendazole | Jun 11, 2017 | Issued |
Array
(
[id] => 17725964
[patent_doc_number] => 11382327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Emulsifiable concentrate of tefluthrin
[patent_app_type] => utility
[patent_app_number] => 16/308198
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4697
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308198 | Emulsifiable concentrate of tefluthrin | Jun 1, 2017 | Issued |
Array
(
[id] => 12660289
[patent_doc_number] => 20180111929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 15/605856
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 145031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15605856
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/605856 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | May 24, 2017 | Abandoned |
Array
(
[id] => 11942151
[patent_doc_number] => 20170246303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'NANOEMULSIONS'
[patent_app_type] => utility
[patent_app_number] => 15/595232
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7370
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15595232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/595232 | NANOEMULSIONS | May 14, 2017 | Abandoned |